Community/Retail

On this month's episode hosts Jeremy Sasser and Jessica Langley-Loep from the National Healthcareer Association welcome their guest Christine Cline-Dahlman, BFA, CPhT, the founder and owner of PharmTechForward.

There are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.

Changing one’s diet could change brain health and study results suggest the Mediterranean diet could positively support cognitive function.

New research suggests that 200 g/day of milk can reduce the risk of type 2 diabetes by 10%.

Amendments reflecting more contemporary options could raise ethical questions for health care workers.

Research suggests cannabis can improve quality of life for patients who suffer from pain and neurological disorders.

Researchers will submit a new drug application to the FDA after a phase 3 trial found that iDose TR slow- and fast-release models met their primary endpoint in patients with glaucoma.

Pharmacists should get involved in all the various aspects of their business and with the different professional groups available.

GENDER R25 will provide funding for courses and curricula to improve gender-focused education and equity in pharmacy, as well as other health care fields.

Pharmacists can educate older adults on risk factors and prevention efforts around herpes zoster.

Analytics allow for a better understanding of the needs of various patient populations and the barriers they face in accessing care.

USC Analysis: although generics save US health care systems billions, PBMs jack up prices for employers, government, and patients.

Quadrivalent mRNA influenza vaccine candidate to be evaluated in approximately 25,000 healthy US adults.

Migraines are multifactorial and patient-specific, causing accessible care and treatments to be limited and ignored.

Men with chronically low testosterone levels are more likely to be hospitalized from COVID-19 than those with normal levels, but testosterone therapy could decrease this risk.

Online communities can help opioid users in remission maintain long-lasting sobriety, however the research suggests these communities should be non-drug-related.

Care Coach program offers a comprehensive set of pharmacy and counseling services to patients struggling to manage their diabetes.

Simple steps to minimize risk are easily overlooked when pharmacies get busy.

Many drugs for these conditions enter clinical trials, but few demonstrate success.

DaxibotulinumtoxinA-lanm from Revance Therapeutics Inc is the first peptide-formulated neuromodulator with long-lasting results.

The drug improves kidney function in adults with hepatorenal syndrome with rapid reduction in kidney function.

Researchers found that patients diagnosed with early-onset type 2 diabetes have a greater risk of premature death than the general population.

Deucravacitinib is a selective, allosteric tyrosine kinase 2 (TYK2) inhibitor, which is a member of the Janus kinase (JAK) family.

Alopecia areata is an autoimmune disease with an underlying immuno-inflammatory pathogenesis.

Pharmacists should ascertain whether self-treatment is appropriate and suggest medical care if it isn’t.

Part A results from the 2-part LILAC study show that the therapy significantly reduced disease activity based on active joint count in individuals compared with the placebo.

Study suggests gene therapy may effectively treat young children who were born colorblind via pathways connecting the brain and the retina.

Research suggests that subcutaneous insulin aspart is a cost-effective and accessible treatment option that could allow children with type 1 diabetes to avoid the ICU after a mild episode of diabetic ketoacidosis.